• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为高亲和力5-HT(1A)受体配体的芳基哌嗪的二维定量构效关系研究。

Two-dimensional QSAR studies on arylpiperazines as high-affinity 5-HT(1A) receptor ligands.

作者信息

Weber Karen C, Honório Káthia M, Andricopulo Adriano D, Da Silva Albérico B F

机构信息

Instituto de Química de São Carlos, Universidade de São Paulo, São Carlos, SP, Brazil.

出版信息

Med Chem. 2008 Jul;4(4):328-35. doi: 10.2174/157340608784872325.

DOI:10.2174/157340608784872325
PMID:18673144
Abstract

5-HT(1A) receptor plays an important role in the delayed onset of antidepressant action of a class of selective serotonin reuptake inhibitors. Moreover, 5-HT(1A) receptor levels have been shown to be altered in patients suffering from major depression. In this work, hologram quantitative structure-activity relationship (HQSAR) studies were performed on a series of arylpiperazine compounds presenting affinity to the 5-HT(1A) receptor. The models were constructed with a training set of 70 compounds. The most significant HQSAR model (q(2) = 0.81, r(2) = 0.96) was generated using atoms, bonds, connections, chirality, and donor and acceptor as fragment distinction, with fragment size of 6-9. Predictions for an external test set containing 20 compounds are in good agreement with experimental results showing the robustness of the model. Additionally, useful information can be obtained from the 2D contribution maps.

摘要

5-羟色胺(1A)受体在一类选择性5-羟色胺再摄取抑制剂的抗抑郁作用延迟起效过程中发挥重要作用。此外,在重度抑郁症患者中,5-羟色胺(1A)受体水平已显示发生改变。在本研究中,对一系列对5-羟色胺(1A)受体具有亲和力的芳基哌嗪化合物进行了全息定量构效关系(HQSAR)研究。模型构建采用了70种化合物的训练集。使用原子、键、连接、手性以及供体和受体作为片段区分,片段大小为6 - 9,生成了最显著的HQSAR模型(交叉验证系数q(2) = 0.81,决定系数r(2) = 0.96)。对包含20种化合物的外部测试集的预测与实验结果高度吻合,表明该模型具有稳健性。此外,可从二维贡献图中获得有用信息。

相似文献

1
Two-dimensional QSAR studies on arylpiperazines as high-affinity 5-HT(1A) receptor ligands.作为高亲和力5-HT(1A)受体配体的芳基哌嗪的二维定量构效关系研究。
Med Chem. 2008 Jul;4(4):328-35. doi: 10.2174/157340608784872325.
2
SMILES-based QSAR model for arylpiperazines as high-affinity 5-HT(1A) receptor ligands using CORAL.使用CORAL构建的基于SMILES的芳基哌嗪类作为高亲和力5-HT(1A)受体配体的QSAR模型。
Eur J Pharm Sci. 2013 Feb 14;48(3):532-41. doi: 10.1016/j.ejps.2012.12.021. Epub 2012 Dec 31.
3
Synthesis and structure-activity relationships of a new model of arylpiperazines. Study of the 5-HT(1a)/alpha(1)-adrenergic receptor affinity by classical hansch analysis, artificial neural networks, and computational simulation of ligand recognition.新型芳基哌嗪模型的合成与构效关系。通过经典汉施分析、人工神经网络以及配体识别的计算模拟研究5-羟色胺(1a)/α(1)-肾上腺素能受体亲和力。
J Med Chem. 2001 Jan 18;44(2):198-207. doi: 10.1021/jm000930t.
4
Arylpiperazine derivatives acting at 5-HT(1A) receptors.作用于5-羟色胺(5-HT)1A受体的芳基哌嗪衍生物。
Curr Med Chem. 2002 Feb;9(4):443-69. doi: 10.2174/0929867023371030.
5
Synthesis and structure--activity relationship in a class of indolebutylpiperazines as dual 5-HT(1A) receptor agonists and serotonin reuptake inhibitors.一类吲哚丁基哌嗪作为5-羟色胺(5-HT)1A受体双重激动剂和5-羟色胺再摄取抑制剂的合成及构效关系
J Med Chem. 2004 Sep 9;47(19):4684-92. doi: 10.1021/jm040793q.
6
Synthesis and structure-activity relationships of a new model of arylpiperazines. 5. Study of the physicochemical influence of the pharmacophore on 5-HT(1a)/alpha(1)-adrenergic receptor affinity: synthesis of a new derivative with mixed 5-HT(1a)/d(2) antagonist properties.新型芳基哌嗪模型的合成与构效关系。5. 药效基团对5-羟色胺(1a)/α(1)-肾上腺素能受体亲和力的物理化学影响研究:具有5-羟色胺(1a)/多巴胺(2)混合拮抗剂特性的新衍生物的合成
J Med Chem. 2001 Jan 18;44(2):186-97. doi: 10.1021/jm000929u.
7
A chemometric study of the 5-HT(1A) receptor affinities presented by arylpiperazine compounds.芳基哌嗪化合物对5-HT(1A)受体亲和力的化学计量学研究。
Eur J Med Chem. 2008 Feb;43(2):364-72. doi: 10.1016/j.ejmech.2007.03.036. Epub 2007 Apr 24.
8
Synthesis and pharmacological evaluation of 1-[(1,2-diphenyl-1H-4-imidazolyl)methyl]-4-phenylpiperazines with clozapine-like mixed activities at dopamine D(2), serotonin, and GABA(A) receptors.具有氯氮平样在多巴胺D(2)、5-羟色胺和GABA(A)受体的混合活性的1-[(1,2-二苯基-1H-4-咪唑基)甲基]-4-苯基哌嗪的合成与药理评价
J Med Chem. 2002 Oct 10;45(21):4655-68. doi: 10.1021/jm020848t.
9
Computational methods in determination of pharmacophore models of 5-HT(1A), 5-HT(2A) and 5-HT(7) receptors.计算方法在确定 5-HT(1A)、5-HT(2A)和 5-HT(7)受体的药效基团模型中的应用。
Mini Rev Med Chem. 2013 Jun;13(7):933-51. doi: 10.2174/1389557511313070001.
10
Hologram quantitative structure-activity relationships for a series of farnesoid X receptor activators.一系列法尼醇X受体激活剂的全息定量构效关系
Bioorg Med Chem Lett. 2005 Jun 15;15(12):3119-25. doi: 10.1016/j.bmcl.2005.04.017.

引用本文的文献

1
3D-QSAR design of new escitalopram derivatives for the treatment of major depressive disorders.用于治疗重度抑郁症的新型艾司西酞普兰衍生物的3D-QSAR设计
Sci Pharm. 2010 Apr-Jun;78(2):233-48. doi: 10.3797/scipharm.0912-22. Epub 2010 May 5.
2
Fragment-based QSAR: perspectives in drug design.基于片段的定量构效关系:药物设计中的前景
Mol Divers. 2009 Aug;13(3):277-85. doi: 10.1007/s11030-009-9112-5. Epub 2009 Jan 31.